Patent details
EP3849534 Title: COMBINATION OF DASATINIB AND ADAGRASIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Basic Information
- Publication number:
- EP3849534
- PCT Application Number:
- US2019050224
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP198588832
- PCT Publication Number:
- WO2020055755
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF DASATINIB AND ADAGRASIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
- French Title of Invention:
- COMBINAISON DU DASATINIB ET DE L'ADAGRASIB POUR SON UTILISATION DANS LE TRATEMENT DU CANCER BRONCHIQUE NON À PETITES CELLULES
- German Title of Invention:
- KOMBINATION VON DASATINIB UND ADAGRASIB ZUR BEHANDLUNG VON NICHT-KLEINZELLIGEM LUNGENKARZINOM
- SPC Number:
Dates
- Filing date:
- 09/09/2019
- Grant date:
- 05/03/2025
- EP Publication Date:
- 21/07/2021
- PCT Publication Date:
- 19/03/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2025
- EP B1 Publication Date:
- 05/03/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/09/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2025
- Name:
- Mirati Therapeutics, Inc.
- Address:
- Route 206 and Province Line Road, Princeton, New Jersey 08543, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 11/03/2025
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- OLSON, Peter
- Address:
- United States (US)
2
- Name:
- ARANDA, Ruth, Wei
- Address:
- United States (US)
3
- Name:
- ENGSTROM, Lars, Daniel
- Address:
- United States (US)
4
- Name:
- CHRISTENSEN, James, Gail
- Address:
- United States (US)
Priority
- Priority Number:
- 201862729169 P
- Priority Date:
- 10/09/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/5025; A61K 31/506; A61K 31/517; A61K 31/519; A61K 31/5377; A61K 31/541; A61K 31/553; A61K 45/06; A61P 35/00; A61P 35/02; A61K 9/00;
Publication
European Patent Bulletin
- Issue number:
- 202510
- Publication date:
- 05/03/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 82 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 11/03/2025 | Power Of Attorney | 1 |
| 12/03/2025 | Outgoing Correspondence | 1 |